←
TranscriptomeSciInc213 posts
TranscriptomeSciInc avatar

TranscriptomeSciInc

@TranscriptomeSI

Genomics company changing patient care through molecular diagnostics and the Molecular Microscope® (MMDx®) service.

◷ Joined April 2016▧ 91 Photos and videos
JHLT avatar
⟳ TranscriptomeSciInc retweeted
JHLT@TheJHLT·Jul 17

In Trifecta-Heart, #HeartTransplant ABMR was ~50% DSA-negative. While DSA-negative molecular ABMR was slightly earlier and less intense than DSA-positive ABMR, dd-cfDNA and molecular features were the same. @TranscriptomeSI 🔗: jhltonline.org/article/S1053…

TranscriptomeSciInc avatar
TranscriptomeSciInc@TranscriptomeSI·27 May 2024

(1) Halloran, P. F., et al. (1990). "The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection." Transplantation 49(1): 85-91.

TranscriptomeSciInc avatar
TranscriptomeSciInc@TranscriptomeSI·27 May 2024

It also suggests that dd-cfDNA could be used to help manage these patients during treatment. We are committed to seeing how this agent can benefit kidney transplants with ABMR in a controlled phase 3 trial, hopefully led by our collaborators in Vienna and Berlin.